1. Market Research
  2. > Healthcare Market Trends

Vital Signs - Healthcare News - The Analyst's Perspective February 2014 Issue

  • February 2014
  • 5 pages
  • Frost & Sullivan
Report ID: 1868688

Summary

Table of Contents

Amgen and Illumina Enter Agreement to Develop Oncology Companion Diagnostic Test

The Californian sequencing instrumentation leader, Illumina, entered into a partnership with Amgen to develop and commercialize a multigene next generation sequencing (NGS) based companion diagnostic test for the targeted drug Vectibix in metastatic colorectal cancer. This partnership marks Illumina’s entry into the NGS personalized medicine segment.

The Analyst’s Perspective by Divyaa Ravishankar, Senior Industry Analyst, Life Science North America

Various life science tools manufacturers have entered the companion diagnostic market segment in the last two years. The Amgen-Illumina partnership will be developing one of the first NGS-based companion diagnostic assays. The partnership leverages Illumina’s market leadership in NGS research platforms. The partnership also delivers a geographic advantage in the U.S. and Europe, which leads to an easier roadmap to address regulatory challenges. Illumina’s MiSeq sequencer has lowered the cost of sequencing relative to the competition, making it a suitable platform to develop the multi-gene test. Amgen partnered with Illumina for its strong track record in the commercialization of novel personalized medicine products. Examples include a partnership with DxS in 2008 for the KRAS companion diagnostic test and a partnership with Dako in 2012 for another companion diagnostic test associated with a rare cancer treatment.
NGS enables patient tumor genetic profiling and the NGS market segment is rapidly moving toward clinical diagnostics for its advantages to detect a large number of mutations simultaneously and affordably. Resulting from this work, physicians can choose the best possible treatment option personalized to the patient. In the next few years, Illumina will reap benefits from this novel diagnostic test, which will position the company in the high growth companion diagnostic segment.

Nestlé Launches New Dermatology Subsidiary Through Complete Acquisition of Galderma

Nestlé has made another strategic move in their transition toward a more healthcare focused company, with the full acquisition of dermatology specialty company, Galderma. Nestlé will fund this transaction with the sale of 48.5 million shares of Loréal in which Nestlé gains a 50% stake in Galderma from Loréal, resulting in 100% ownership of Galderma. Galderma will be the foundation of a new subsidiary, Nestlé Skin Health S.A. The transaction is pending regulatory approval.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Infectious Disease Testing Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • May 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Virology and Bacteriology Testing Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 59500
  • Industry report
  • June 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

Automated Microbiology Market 2021: A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification

  • $ 52500
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.